Monotherapy versus combined androgen blockade in patients with advanced prostate cancer

Clinically relevant endpoints and quality-of-life outcomes with darolutamide in patients with metastatic hormone-sensitive prostate cancer: Analyses of the phase III ARASENS trial.

European journal of cancer (Oxford, England : 1990)·2026

Robust Meta-Analysis of a Clinical Cell-Cycle Risk (CCR) Score Demonstrates Broadly Applicable Metastasis and Disease-Specific Mortality Risk Stratification in Men With Localized Prostate Cancer.

Clinical genitourinary cancer·2026

Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is Now.

JCO oncology practice·2024

Implementing evidence-based strategies for men with biochemically recurrent and advanced prostate cancer: Consensus recommendations from the US Prostate Cancer Conference 2024.

Cancer·2024

Darolutamide in Japanese patients with metastatic hormone-sensitive prostate cancer: Phase 3 ARASENS subgroup analysis.

Cancer medicine·2024

Germline genetic testing for prostate cancer: Ordering trends in the era of expanded hereditary cancer screening recommendations.

Urologic oncology·2024

Male survivors of childhood cancer and perceptions of sexual dysfunction risk: A report from the Childhood Cancer Survivor Study.

Cancer·2026

T-cell engagers in small cell lung cancer.

Cancer·2026

The evolving role of immunotherapy in ovarian cancer.

Cancer·2026

Prevalence of breast, cervical, and colorectal cancer screening among adults according to disability type and difficulty level, United States, 2021 and 2023.

Cancer·2026

Elevated risk of ischemic stroke after invasive cancer diagnosis: A nationwide population-based study.

Cancer·2026

Long-term outcomes and patterns of failure in patients with thymic malignancies treated with surgery and radiation therapy.

Cancer·2026

Postoperative radiotherapy or chemoradiotherapy versus surgery only in non-metastatic head and neck adenoid cystic carcinoma: a retrospective analysis.

Translational cancer research·2026

Efficacy and safety of PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone in stage IIIB-IV squamous non-small cell lung cancer: a systematic review and meta-analysis of phase 3 randomized controlled trials.

Translational cancer research·2026

Erratum: Nomogram for predicting cancer-specific mortality risk in endometrial cancer after postoperative radiotherapy.

Translational cancer research·2026

Neoadjuvant anthracycline-containing vs. anthracycline-free chemotherapy with dual HER2 blockade in HER2-Positive breast cancer: a Systematic Review and meta-analysis.

Open medicine (Warsaw, Poland)·2026

The expert consensus document on minimally invasive upper lobectomy for lung cancer in China.

Journal of thoracic disease·2026

Belzutifan-Associated Reversible Heart Failure With Preserved Ejection Fraction in Metastatic Renal Cell Carcinoma.

IJU case reports·2026

Related Experiment Videos

Monotherapy versus combined androgen blockade in patients with advanced prostate cancer

Related Concept Videos

Clinically relevant endpoints and quality-of-life outcomes with darolutamide in patients with metastatic hormone-sensitive prostate cancer: Analyses of the phase III ARASENS trial.

Robust Meta-Analysis of a Clinical Cell-Cycle Risk (CCR) Score Demonstrates Broadly Applicable Metastasis and Disease-Specific Mortality Risk Stratification in Men With Localized Prostate Cancer.

Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is Now.

Implementing evidence-based strategies for men with biochemically recurrent and advanced prostate cancer: Consensus recommendations from the US Prostate Cancer Conference 2024.

Darolutamide in Japanese patients with metastatic hormone-sensitive prostate cancer: Phase 3 ARASENS subgroup analysis.

Germline genetic testing for prostate cancer: Ordering trends in the era of expanded hereditary cancer screening recommendations.

Male survivors of childhood cancer and perceptions of sexual dysfunction risk: A report from the Childhood Cancer Survivor Study.

T-cell engagers in small cell lung cancer.

The evolving role of immunotherapy in ovarian cancer.

Prevalence of breast, cervical, and colorectal cancer screening among adults according to disability type and difficulty level, United States, 2021 and 2023.

Elevated risk of ischemic stroke after invasive cancer diagnosis: A nationwide population-based study.

Long-term outcomes and patterns of failure in patients with thymic malignancies treated with surgery and radiation therapy.

Postoperative radiotherapy or chemoradiotherapy versus surgery only in non-metastatic head and neck adenoid cystic carcinoma: a retrospective analysis.

Efficacy and safety of PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone in stage IIIB-IV squamous non-small cell lung cancer: a systematic review and meta-analysis of phase 3 randomized controlled trials.

Erratum: Nomogram for predicting cancer-specific mortality risk in endometrial cancer after postoperative radiotherapy.

Neoadjuvant anthracycline-containing vs. anthracycline-free chemotherapy with dual HER2 blockade in HER2-Positive breast cancer: a Systematic Review and meta-analysis.

The expert consensus document on minimally invasive upper lobectomy for lung cancer in China.

Belzutifan-Associated Reversible Heart Failure With Preserved Ejection Fraction in Metastatic Renal Cell Carcinoma.

Related Experiment Videos

Monotherapy versus combined androgen blockade in patients with advanced prostate cancer

Related Concept Videos

Related Articles